Cara Therapeutics Inc (NASDAQ:CARA)

BATS BZX Real-Time Price
As of Oct 06
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cara Therapeutics Inc have a median target of 27.00, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a +178.64% increase from the last price of 9.69.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Cara Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -407.14%
Growthannually 28.74%


Growthquarterly -57.18%
Growthannually 161.91%
Key to the earnings and sales forecast charts.